Clinical Trials in Tennessee

Showing 3381-3400 of 20,239 trials

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer therapy alone to subjects from an Incyte-sponsored study of ruxolitinib that has reached its study objectives or has been terminated. This study will also provide another mechanism for reporting adverse events related to study drug safety.

Pancreatic CancerColorectal Cancer (CRC)Breast Cancer+1 more

Incyte Corporation10 participantsStarted Nov 2016

Santa Monica, California, United States • Louisville, Kentucky, United States • Clifton Park, New York, United States +6 more locations

Enrolling By InvitationPhase 229 miles

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

NCT06992440

Randomized, triple-masked, parallel arm clinical trial of empagliflozin versus placebo in pulmonary arterial hypertension (PAH) participants on stable approved PAH-targeted medical therapy.

Pulmonary Arterial Hypertension

Gustavo A Heresi, MD, MS78 participantsStarted Jun 2025

Baltimore, Maryland, United States • Cleveland, Ohio, United States • Nashville, Tennessee, United States

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

Find Trials by Condition in Tennessee

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Diabetes Medical Nutrition Therapy in Southeastern African American Women

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

A Peer-Led Intervention to Improve Postpartum Retention in HIV Care

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Improving Parental Support in Hypospadias Care

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG